Developer docs
API playgroundTry for free, no card

Search company profiles

Argonaut Manufacturing Services

Full company profile

uuid0000ob8

Namestring
Argonaut Manufacturing Services
Legal namestring
Argonaut Manufacturing Services, Incorporated
Websiteurl
argonautms.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Argonaut Manufacturing Services is a Carlsbad, California-based contract development and manufacturing organization (CDMO) founded in 2016 that provides aseptic fill-finish, lyophilization, in-vitro diagnostics (IVD) manufacturing, and drug-device combination product (DDCP) services to biopharmaceutical, molecular diagnostics, and life sciences customers. Core technical capabilities center on isolator-based aseptic filling of vials, syringes, and cartridges under cGMP, supported by proprietary lyophilization platforms including LyoDots (miniaturized reagent format) and LyoDose (lyophilized bead technology for 96/384-well plates), plus the BioFuse sample-prep device for point-of-care workflows. The company operates five facilities in Carlsbad, holds ISO 13485:2016, cGMP, 21 CFR 210/211/820, and California FDB certifications, and its founding leadership has collective experience navigating 40+ FDA pre-approval inspections.

The business model is professional services plus per-batch contract manufacturing under multi-year agreements, with quote-based pricing that varies by product type, batch size, regulatory pathway, and scope. Revenue is generated through project-based development, clinical supply batches, and commercial supply agreements, with go-to-market executed via direct enterprise field sales, strategic ecosystem partners (KBI Biopharma, Abzena, Avid Bioservices, Cytiva, Ensera), and event-driven demand generation. Named customers include Bluejay Diagnostics, the Broad Institute (Vallabh/Minikel Lab for siRNA prion-disease therapeutics), n-Lorem Foundation (ASO medicines for nano-rare diseases), and UC San Diego Health. As of 2023 the company employed 133 FTEs with stated plans to scale to 300 while tripling revenue over five years, funded by a $45 million equity round in March 2024 led by NewVale Capital with Telegraph Hill Partners.

Short descriptiontext

Argonaut Manufacturing Services is a Carlsbad, CA-based contract development and manufacturing organization (CDMO) offering aseptic fill-finish, lyophilization, IVD, and drug-device combination product manufacturing services to biopharmaceutical, molecular diagnostics, and life sciences clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract pharmaceutical manufacturing, aseptic fill-finish services, lyophilization manufacturing, drug-device combination products, in-vitro diagnostics manufacturing
Industry3 codes
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Contract Pharmaceutical Manufacturing (CDMO)
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Manufacturing Services
TypeProfessional Services
Description

Service-based contracts for aseptic fill-finish, lyophilization, IVD manufacturing, and drug-device combination products. Revenue generated through project fees, per-batch pricing, and per-unit manufacturing fees under long-term supply agreements.

2Per-Batch Manufacturing
TypeTransaction Fee
Description

Revenue from individual manufacturing batches for clinical and commercial supply, with pricing based on batch size, complexity, and regulatory requirements

3Project-Based Development Services
TypeOne Time License
Description

Revenue from process development, scale-up, and tech transfer services prior to commercial manufacturing

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Custom quote-based pricing tailored to specific manufacturing requirements
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing varies based on product type, batch size, regulatory pathway, and service scope. No standard pricing tiers publicly available.

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1LyoDots
Description

World's smallest lyophilized reagents - miniaturized format for diagnostic and point-of-care devices, stable at room temperature, automation friendly

argonautms.com
+2 more records
Core offering1 text field

Argonaut Manufacturing Services is a contract manufacturing organization (CMO/CDMO) providing aseptic fill-finish, lyophilization (freeze-drying), drug-device combination product assembly, and in-vitro diagnostics (IVD) and life sciences kit manufacturing for biopharmaceutical, diagnostics, and life science companies. Services include sterile liquid filling, non-sterile fill-finish, analytical and quality control testing, and GMP storage and logistics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 100+ completed client programs delivered successfully
+1 more record
Product overview1 text field

Argonaut Manufacturing Services is a contract development and manufacturing organization (CDMO) offering a comprehensive suite of pharmaceutical and life sciences manufacturing services. The core offerings include aseptic fill-finish services for vials, syringes, and cartridges; drug-device combination products (DDCP); in-vitro diagnostics and life sciences kit manufacturing; and lyophilization services including proprietary LyoDots and LyoDose bead technology. Supporting services include analytical/quality control, GMP storage and logistics, and non-sterile fill-finish with terminal sterilization. The company operates from Carlsbad, CA with isolator-based filling lines compliant with Annex 1 and FDA standards.

Product and service9 records
1Aseptic Fill & Finish Services
CategorySterile Manufacturing Services
Description

Sterile liquid filling of injectable drug products using isolator-based aseptic processing for biopharmaceutical clients requiring FDA-registered cGMP capacity.

2Lyophilization Services
3Drug-Device Combination Products
4In-Vitro Diagnostics (IVD) and Life Sciences Kits
5Non-Sterile Fill Finish
6BioFuse Sample Prep Device
CategorySample Preparation Devices
Description

A proprietary sample preparation device developed by Argonaut for use in diagnostic and life science workflows.

7LyoDots
CategoryLyophilization Technology
Description

A proprietary lyophilization technology platform developed by Argonaut for freeze-drying applications.

8Analytical & Quality Control Services
9GMP Storage & Logistics
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Ensera Therapeutics
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-15
Description

Partnership for drug-device combination product manufacturing. Argonaut provides expertise in combining pharmaceutical compounds with medical device components for integrated therapeutic products.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Manufacturing partnership for Symphony platform diagnostic products. Argonaut provides IVD manufacturing capabilities for Bluejay's point-of-care diagnostic technology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Manufacturing partnership for siRNA therapeutic products targeting prion disease. Argonaut provides GMP manufacturing for clinical supply of novel RNA-based therapeutics.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Manufacturing partnership for ASO (antisense oligonucleotide) medicines for nano-rare diseases. Supports n-Lorem's mission to provide free, personalized ASO medicines to patients with nano-rare diseases caused by unique genetic mutations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-20
Description

Partnership for end-to-end drug development support from early discovery through commercial manufacturing. Abzena provides antibody and protein engineering capabilities combined with Argonaut's fill-finish expertise.

6KBI Biopharma
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-01-16
Description

Strategic alliance for integrated drug substance and drug product manufacturing. KBI Biopharma provides drug substance development and manufacturing while Argonaut provides fill-finish and drug product manufacturing capabilities. Awarded Fill-Finish CDMO of the Year recognition in 2026.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic CDMO partnership for integrated biologics manufacturing from cell line development through fill-finish.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership for brain delivery therapeutics and diagnostics manufacturing.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global CDMO providing integrated drug development, manufacturing, and packaging services including drug-device combination products. PCI competes directly with Argonaut in combination product manufacturing and aseptic fill-finish, but at significantly greater scale and geographic breadth.

2KBI Biopharma
TypeDirect peer
Description

Biologics-focused CDMO offering drug substance development and manufacturing. KBI is Argonaut's flagship strategic partner and directly adjacent in the biopharma manufacturing value chain—KBI handles drug substance while Argonaut handles fill-finish, making them both collaborators and competitors for integrated contracts.

TypeDirect peer
Description

Aseptic fill-finish CDMO offering sterile injectable manufacturing for clinical and commercial supply. GRAM is a similar-scale mid-sized competitor to Argonaut in the aseptic fill-finish market, targeting similar biopharma clients with overlapping service offerings.

TypeDirect peer
Description

CDMO specializing in fill-finish of viral vectors, vaccines, and live biologics. Vibalogics competes directly with Argonaut for aseptic fill-finish contracts in the biologics space, particularly for clinical and commercial supply of complex biopharmaceuticals.

TypeDirect peer
Description

Biopharma services organization offering antibody engineering, protein development, and manufacturing services. Abzena is Argonaut's Core strategic partner for end-to-end drug development, and competes for integrated biopharmaceutical development and manufacturing contracts.

TypeRegional player
Description

Swiss-based CDMO specializing in sterile fill-finish of liquid and lyophilized vials for clinical and commercial supply. Baccinex competes with Argonaut in aseptic fill-finish but primarily serves European biopharma clients, providing a regional comparison point.

TypeDirect peer
Description

CDMO specializing in biologics manufacturing from cell line development through fill-finish. Avid is both a strategic CDMO partner of Argonaut (per their partnership data) and a competitor for integrated biologics manufacturing engagements with biopharma clients.

TypeBroad incumbent
Description

One of the largest global CDMOs offering comprehensive drug development, biologics manufacturing, and fill-finish services across dozens of facilities worldwide. Catalent is a broad incumbent competitor whose scale and breadth compete with Argonaut for large commercial contracts.

9Recipharm
TypeBroad incumbent
Description

European-headquartered CDMO providing contract development and manufacturing services including sterile fill-finish and biologics. Recipharm competes with Argonaut in the broader fill-finish CDMO market, particularly for European-sourced contracts.

TypeEmerging player
Description

Emerging aseptic fill-finish CDMO offering sterile injectable manufacturing with recent capacity expansions. INCOG is a similar-stage emerging competitor to Argonaut, both having recently built or expanded capacity targeting mid-to-large biopharma clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Argonaut Manufacturing Services

Contract Pharmaceutical Manufacturing (CDMO)argonautms.com

Argonaut Manufacturing Services is a Carlsbad, CA-based contract development and manufacturing organization (CDMO) offering aseptic fill-finish, lyophilization, IVD, and drug-device combination product manufacturing services to biopharmaceutical, molecular diagnostics, and life sciences clients.

What Argonaut Manufacturing Services does

Argonaut Manufacturing Services is a Carlsbad, California-based contract development and manufacturing organization (CDMO) founded in 2016 that provides aseptic fill-finish, lyophilization, in-vitro diagnostics (IVD) manufacturing, and drug-device combination product (DDCP) services to biopharmaceutical, molecular diagnostics, and life sciences customers. Core technical capabilities center on isolator-based aseptic filling of vials, syringes, and cartridges under cGMP, supported by proprietary lyophilization platforms including LyoDots (miniaturized reagent format) and LyoDose (lyophilized bead technology for 96/384-well plates), plus the BioFuse sample-prep device for point-of-care workflows. The company operates five facilities in Carlsbad, holds ISO 13485:2016, cGMP, 21 CFR 210/211/820, and California FDB certifications, and its founding leadership has collective experience navigating 40+ FDA pre-approval inspections.

The business model is professional services plus per-batch contract manufacturing under multi-year agreements, with quote-based pricing that varies by product type, batch size, regulatory pathway, and scope. Revenue is generated through project-based development, clinical supply batches, and commercial supply agreements, with go-to-market executed via direct enterprise field sales, strategic ecosystem partners (KBI Biopharma, Abzena, Avid Bioservices, Cytiva, Ensera), and event-driven demand generation. Named customers include Bluejay Diagnostics, the Broad Institute (Vallabh/Minikel Lab for siRNA prion-disease therapeutics), n-Lorem Foundation (ASO medicines for nano-rare diseases), and UC San Diego Health. As of 2023 the company employed 133 FTEs with stated plans to scale to 300 while tripling revenue over five years, funded by a $45 million equity round in March 2024 led by NewVale Capital with Telegraph Hill Partners.

Argonaut Manufacturing Services firmographics

Firmographics
Name
Argonaut Manufacturing Services
Legal name
Argonaut Manufacturing Services, Incorporated
Website
https://argonautms.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
101–250 employees
Short description
Argonaut Manufacturing Services is a Carlsbad, CA-based contract development and manufacturing organization (CDMO) offering aseptic fill-finish, lyophilization, IVD, and drug-device combination product manufacturing services to biopharmaceutical, molecular diagnostics, and life sciences clients.
Ownership category
akta.pro rank

Argonaut Manufacturing Services industry classification

Industry
Product category
Contract Pharmaceutical Manufacturing (CDMO)
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Medical Equipment and Supplies Manufacturing (3391)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Contract pharmaceutical manufacturing
  • Aseptic fill-finish services
  • Lyophilization manufacturing
  • Drug-device combination products
  • In-vitro diagnostics manufacturing

Where Argonaut Manufacturing Services is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Argonaut Manufacturing Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Service-based contracts for aseptic fill-finish, lyophilization, IVD manufacturing, and drug-device combination products. Revenue generated through project fees, per-batch pricing, and per-unit manufacturing fees under long-term supply agreements.
  2. Per-Batch Manufacturing: Revenue from individual manufacturing batches for clinical and commercial supply, with pricing based on batch size, complexity, and regulatory requirements
  3. Project-Based Development Services: Revenue from process development, scale-up, and tech transfer services prior to commercial manufacturing

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom quote-based pricing tailored to specific manufacturing requirements

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Argonaut Manufacturing Services product offering

Product offering

Core offering

Argonaut Manufacturing Services is a contract manufacturing organization (CMO/CDMO) providing aseptic fill-finish, lyophilization (freeze-drying), drug-device combination product assembly, and in-vitro diagnostics (IVD) and life sciences kit manufacturing for biopharmaceutical, diagnostics, and life science companies. Services include sterile liquid filling, non-sterile fill-finish, analytical and quality control testing, and GMP storage and logistics.

Product overview

Argonaut Manufacturing Services is a contract development and manufacturing organization (CDMO) offering a comprehensive suite of pharmaceutical and life sciences manufacturing services. The core offerings include aseptic fill-finish services for vials, syringes, and cartridges; drug-device combination products (DDCP); in-vitro diagnostics and life sciences kit manufacturing; and lyophilization services including proprietary LyoDots and LyoDose bead technology. Supporting services include analytical/quality control, GMP storage and logistics, and non-sterile fill-finish with terminal sterilization. The company operates from Carlsbad, CA with isolator-based filling lines compliant with Annex 1 and FDA standards.

Differentiator

Problem solved

Functional benefit

Brands

  • LyoDots: World's smallest lyophilized reagents - miniaturized format for diagnostic and point-of-care devices, stable at room temperature, automation friendly
  • BioFuse
  • LyoDose

Products and services

  • Aseptic Fill & Finish Services Sterile liquid filling of injectable drug products using isolator-based aseptic processing for biopharmaceutical clients requiring FDA-registered cGMP capacity.
  • Lyophilization Services
  • Drug-Device Combination Products
  • In-Vitro Diagnostics (IVD) and Life Sciences Kits
  • Non-Sterile Fill Finish
  • BioFuse Sample Prep Device A proprietary sample preparation device developed by Argonaut for use in diagnostic and life science workflows.
  • LyoDots A proprietary lyophilization technology platform developed by Argonaut for freeze-drying applications.
  • Analytical & Quality Control Services
  • GMP Storage & Logistics

Quantifiable outcome

  • 100+ completed client programs delivered successfully
  • +1 more outcomes

Companies that use Argonaut Manufacturing Services

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Argonaut Manufacturing Services technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Argonaut Manufacturing Services partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

  • Ensera TherapeuticscoreStrategic or Co-development Partner · 15 June 2026Partnership for drug-device combination product manufacturing. Argonaut provides expertise in combining pharmaceutical compounds with medical device components for integrated therapeutic products.
  • Bluejay DiagnosticscoreStrategic or Co-development Partner · 1 January 2026Manufacturing partnership for Symphony platform diagnostic products. Argonaut provides IVD manufacturing capabilities for Bluejay's point-of-care diagnostic technology.
  • Broad Institute (Vallabh/Minikel Lab)coreStrategic or Co-development Partner · 1 January 2026Manufacturing partnership for siRNA therapeutic products targeting prion disease. Argonaut provides GMP manufacturing for clinical supply of novel RNA-based therapeutics.
  • n-Lorem FoundationflagshipStrategic or Co-development Partner · 1 January 2026Manufacturing partnership for ASO (antisense oligonucleotide) medicines for nano-rare diseases. Supports n-Lorem's mission to provide free, personalized ASO medicines to patients with nano-rare diseases caused by unique genetic mutations.
  • AbzenacoreStrategic or Co-development Partner · 20 June 2024Partnership for end-to-end drug development support from early discovery through commercial manufacturing. Abzena provides antibody and protein engineering capabilities combined with Argonaut's fill-finish expertise.
  • KBI BiopharmaflagshipStrategic or Co-development Partner · 16 January 2024Strategic alliance for integrated drug substance and drug product manufacturing. KBI Biopharma provides drug substance development and manufacturing while Argonaut provides fill-finish and drug product manufacturing capabilities. Awarded Fill-Finish CDMO of the Year recognition in 2026.
  • Avid BioservicescoreStrategic or Co-development PartnerStrategic CDMO partnership for integrated biologics manufacturing from cell line development through fill-finish.
  • BrainSporesminorStrategic or Co-development PartnerStrategic partnership for brain delivery therapeutics and diagnostics manufacturing.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Argonaut Manufacturing Services competitors and assessment

Company assessment

Direct peers

  • PCI Pharma Services: Global CDMO providing integrated drug development, manufacturing, and packaging services including drug-device combination products. PCI competes directly with Argonaut in combination product manufacturing and aseptic fill-finish, but at significantly greater scale and geographic breadth.
  • KBI Biopharma: Biologics-focused CDMO offering drug substance development and manufacturing. KBI is Argonaut's flagship strategic partner and directly adjacent in the biopharma manufacturing value chain—KBI handles drug substance while Argonaut handles fill-finish, making them both collaborators and competitors for integrated contracts.
  • Grand River Aseptic Manufacturing: Aseptic fill-finish CDMO offering sterile injectable manufacturing for clinical and commercial supply. GRAM is a similar-scale mid-sized competitor to Argonaut in the aseptic fill-finish market, targeting similar biopharma clients with overlapping service offerings.
  • Vibalogics: CDMO specializing in fill-finish of viral vectors, vaccines, and live biologics. Vibalogics competes directly with Argonaut for aseptic fill-finish contracts in the biologics space, particularly for clinical and commercial supply of complex biopharmaceuticals.
  • Abzena: Biopharma services organization offering antibody engineering, protein development, and manufacturing services. Abzena is Argonaut's Core strategic partner for end-to-end drug development, and competes for integrated biopharmaceutical development and manufacturing contracts.
  • Avid Bioservices: CDMO specializing in biologics manufacturing from cell line development through fill-finish. Avid is both a strategic CDMO partner of Argonaut (per their partnership data) and a competitor for integrated biologics manufacturing engagements with biopharma clients.

Regional players

  • Baccinex: Swiss-based CDMO specializing in sterile fill-finish of liquid and lyophilized vials for clinical and commercial supply. Baccinex competes with Argonaut in aseptic fill-finish but primarily serves European biopharma clients, providing a regional comparison point.

Broad incumbents

  • Catalent: One of the largest global CDMOs offering comprehensive drug development, biologics manufacturing, and fill-finish services across dozens of facilities worldwide. Catalent is a broad incumbent competitor whose scale and breadth compete with Argonaut for large commercial contracts.
  • Recipharm: European-headquartered CDMO providing contract development and manufacturing services including sterile fill-finish and biologics. Recipharm competes with Argonaut in the broader fill-finish CDMO market, particularly for European-sourced contracts.

Emerging players

  • INCOG BioPharma Services: Emerging aseptic fill-finish CDMO offering sterile injectable manufacturing with recent capacity expansions. INCOG is a similar-stage emerging competitor to Argonaut, both having recently built or expanded capacity targeting mid-to-large biopharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Argonaut Manufacturing Services social profiles

Digital presence

Argonaut Manufacturing Services compliance and trust

Trust signal

Compliance7 records

Argonaut Manufacturing Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Argonaut Manufacturing Services leadership team

Management profile

Number of profiles

Profiles12 records

Argonaut Manufacturing Services funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Argonaut Manufacturing Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Argonaut Manufacturing Services

What does Argonaut Manufacturing Services do?

Argonaut Manufacturing Services is a contract manufacturing organization (CMO/CDMO) providing aseptic fill-finish, lyophilization (freeze-drying), drug-device combination product assembly, and in-vitro diagnostics (IVD) and life sciences kit manufacturing for biopharmaceutical, diagnostics, and life science companies. Services include sterile liquid filling, non-sterile fill-finish, analytical and quality control testing, and GMP storage and logistics.

Is Argonaut Manufacturing Services a public or private company?

Argonaut Manufacturing Services is a private company. It is classified as venture growth investor backed and is currently operating.

When was Argonaut Manufacturing Services founded?

Argonaut Manufacturing Services was founded in 2016. It employs 101 to 250 people.

Where is Argonaut Manufacturing Services based?

Argonaut Manufacturing Services is headquartered in Carlsbad, United States, in the North America region.

How does Argonaut Manufacturing Services make money?

Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are per-Batch Manufacturing and project-Based Development Services.

Who are Argonaut Manufacturing Services's main competitors?

Direct peers on record are PCI Pharma Services, KBI Biopharma, Grand River Aseptic Manufacturing, Vibalogics, Abzena and Avid Bioservices. Baccinex is listed as a regional player. Broad incumbents are Catalent and Recipharm. INCOG BioPharma Services is listed as an emerging player.

Does Argonaut Manufacturing Services have an API?

No public API is recorded for Argonaut Manufacturing Services.

What industry is Argonaut Manufacturing Services in?

Argonaut Manufacturing Services's product category is Contract Pharmaceutical Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 32541 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsCollectiveMinds LLC Facilitates J.D. Mowery's Addition to Argonaut Manufacturing BoardCollectiveMinds LLC facilitated J.D. Mowery's appointment to the board of Argonaut Manufacturing Services on October 8, 2026. Mowery, with over two decades of biopharmaceutical manufacturing experience, brings expertise in sterile fill-finish operations. The appointment aims to strengthen Argonaut's leadership and competitive edge in the CDMO sector.PR NewswireCollectiveMinds LLC Supports the Appointment of J.D. Mowery to Argonaut Manufacturing Services Board of DirectorsCollectiveMinds LLC supported Telegraph Hill Partners in identifying J.D. Mowery for Argonaut Manufacturing Services' board, announced September 30, 2026. Mowery brings over two decades of biopharmaceutical manufacturing leadership, including roles at Bora Pharmaceuticals and KBI Biopharma. He will complement Argonaut's management team as a sterile fill-finish CDMO.BioSpaceArgonaut Manufacturing Services Appoints J.D. Mowery to Board of DirectorsArgonaut Manufacturing Services appointed J.D. Mowery to its Board of Directors. Mowery brings over two decades of leadership experience, most recently as President of the global CDMO division at Bora Pharmaceuticals. He will support Argonaut's expansion and client support from clinical through commercial manufacturing.Business Wire BlogArgonaut Manufacturing Services Appoints J.D. Mowery to Board of DirectorsArgonaut Manufacturing Services appointed J.D. Mowery to its Board of Directors. Mowery brings over two decades of leadership experience, including as President of Bora Pharmaceuticals' global CDMO division and CEO of KBI Biopharma. He will support Argonaut's expansion and client support from clinical through commercial manufacturing.Mpo-magEnsera Establishes Alliance Network to Address Combination Product ComplexityEnsera launched the Ensera Alliance Network, bringing together device platform and fill-finish specialists to address combination product commercialization complexity. The network includes SHL Medical, Stevanato Group, Ypsomed, Argonaut Manufacturing Services, and American Injectables, with non-exclusive participation. Ensera plans to expand the network over time.FiercePharmaCDMO Argonaut sheds life sciences, diagnostics division for undisclosed sumArgonaut Manufacturing Services sold its life sciences and diagnostics unit to private equity firm 1315 Capital for an undisclosed sum. The spun-off division, formed in 2016, will operate as an independent CDMO named Aluris Sciences. Argonaut will use the proceeds for core operations and to expand its fill-finish capacity in Carlsbad, California.BioSpaceArgonaut Manufacturing Services Divests Life Sciences and Diagnostics Division to 1315 CapitalArgonaut Manufacturing Services completed the sale of its Life Sciences and Diagnostics division to 1315 Capital, which will operate as Aluris Sciences. The transaction left Argonaut's ownership with Telegraph Hill Partners, New Vale Capital, and management, and proceeds will be reinvested in core operations. No client action or change control is required.FinancialContent Business PageArgonaut Manufacturing Services Divests Life Sciences and Diagnostics Division to 1315 CapitalArgonaut Manufacturing Services completed the sale of its Life Sciences and Diagnostics division to 1315 Capital, which will operate as Aluris Sciences. The transaction left Argonaut's ownership with Telegraph Hill Partners, New Vale Capital, and management, and proceeds will be reinvested in core operations. No client action or change control is required.MorningstarArgonaut Manufacturing Services Divests Life Sciences and Diagnostics Division to 1315 CapitalArgonaut Manufacturing Services completed the sale of its Life Sciences and Diagnostics division to 1315 Capital, forming Aluris Sciences. The transaction left Argonaut's ownership with Telegraph Hill Partners, New Vale Capital, and management, and proceeds will be reinvested in core operations. No drug product programs or client actions were affected.Venture Capital Access OnlineArgonaut Manufacturing Services Divests Life Sciences and Diagnostics Division to 1315 CapitalArgonaut Manufacturing Services completed the sale of its Life Sciences and Diagnostics division to 1315 Capital, which will operate as Aluris Sciences. The transaction left Argonaut's ownership with Telegraph Hill Partners, New Vale Capital, and management, and proceeds will be reinvested in core operations. No client action or change control is required.